
When entering the specialty pharmaceuticals arena, manufacturers need to evaluate the capabilities of their channel partners carefully
When entering the specialty pharmaceuticals arena, manufacturers need to evaluate the capabilities of their channel partners carefully
Published: February 27th 2013 | Updated: